Regulatory Intelligence

Regulatory intelligence helps organizations stay compliant and ahead of evolving drug safety requirements.

Role of Regulatory Intelligence

Regulatory Intelligence relates to the gathering, analyzing, and application of knowledge about regulatory updates to the ever-evolving requirements and guidelines relating to drug safety. Maintaining up- to- date knowledge of Regulatory Intelligence ensures that CROs and Pharmaceutical companies remain compliant with current reporting responsibilities, as well as surveillance requirements and risk management.

Regulatory Intelligence has many practical applications, including:

  • Regulatory Compliance
  • Drug Safety Monitoring
  • Market expansion
  • Crisis and/or Risk Management
  • Regulatory Audits and Inspections
  • Facilitating Market Access
Business worker holding espresso cup and stack of papers looking forward
Several business professionals having fun at a business meeting

Regulatory Intelligence at Radiofilum Pharmaceutical

Regulatory Intelligence is a key pillar at Radiofilum Pharmaceutical , and aims to simplify compliance, reduce risks, and ensure both Radiofilum Pharmaceutical and our clients stay ahead of any regulatory changes. We achieve this by utilising various Regulatory Intelligence tools, Artificial Intelligence, completing monthly manual reviews of authority websites, as well as having a vast network of local knowledge to collect and evaluate local and global regulations.

The thorough analysis of any findings from each of these sources allows for an up-to-date Regulatory Intelligence Repository that colleagues can access to easily answer queries either internally or from clients. Where the answer isn’t already available, Radiofilum Pharmaceutical has the ability to provide fast turnaround responses to ad-hoc requests for Regulatory Intelligence, going as far as offering one- to- one Regulatory Intelligence consultations.

Having access to the most up-to-date global regulation requirements, and the knowledge to interpret these regulations accurately, makes Radiofilum Pharmaceutical completely qualified to perform submissions all over the world. This applies to periodic and expedited submissions, as well as Post-Marketing and Clinical Aggregate Report submissions, and EU product registration and updates in XEVMPD.

Our top priority at Radiofilum Pharmaceutical is regulatory compliance, ensuring that all submissions are performed in accordance with applicable regulations. Due to our Regulatory Intelligence repository and expert interpretations of requirements, Radiofilum Pharmaceutical is proud to consistently post a greater than 99% compliance rate for regulatory submissions, successfully submitting over 2,000 ICSRs per month to health authorities and ethics committees, and distributing reports on-time to investigators and business partners on behalf of our clients.

For clients utilizing our PV submission services, we offer access to the relevant RI for no additional cost, and for clients not utilizing our submissions services, we offer subscriptions to our PV RI information and updates. This information is provided in three different options that build upon each other, allowing the use of a single format or combination of formats. When you have needs, we have answers. Let us know how we can support you today.

Business professionals discussing data around a conference table

Regulatory Intelligence  Services

Stay ahead of regulatory changes with Radiofilum Pharmaceutical 's expert regulatory intelligence services. Contact us today to learn how we can support your compliance needs.

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
 Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

 Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

 Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow